PLGA (50:50)
PLGA (50:50) (poly (lactic-co-glycolic acid) (50:50) ) is a copolymer of poly lactic acid (PLA) and poly glycolic acid (PGA) which can be used to fabricate devices for drug delivery and tissue engineering applications.
Product Specifications
CAS Number
34346-01-5
Product Name Alternative
Poly (lactic-co-glycolic acid) (50:50)
UNSPSC
12352211
Target
Biochemical Assay Reagents
Type
Oligonucleotides
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/plga-50-50.html
Purity
99.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)C(C)OC(CO[H])=O.[x].[y]
Molecular Formula
(C3H6O3) n. (C2H4O3) n
Molecular Weight
10000-20000
References & Citations
[1]Makadia HK, et al. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers (Basel) . 2011 Sep 1;3 (3) :1377-1397.|[2]Chung TW, Tsai YL, Hsieh JH, Tsai WJ. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. J Microencapsul. 2006;23 (1) :15-27. |[3]Mura S, et al. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomedicine. 2011;6:2591-605.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH033853-01 20 µg
Recombinant Human PDCD1/PD-1/CD279 (C-6His-Avi) Biotinylated
Sign In for Pricing
View Details PKSH033853-02 100 µg
Recombinant Human PDCD1/PD-1/CD279 (C-6His-Avi) Biotinylated
Sign In for Pricing
View Details 
LC400215 20 µg
Vitronectin (VTN) (NM_000638) Human Over-expression Lysate
Sign In for Pricing
View Details